ClinicalTrials.Veeva

Menu

Multisensory Early Oral Administration of Human Milk in Preterm Infants (M-MILK)

Loyola University logo

Loyola University

Status

Completed

Conditions

Infant Development
Stress

Treatments

Other: Multisensory Early Oral Administration of Human Milk (M-MILK)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aims of this pilot are to determine the feasibility and acceptability of the Multisensory early oral administration of human milk (M-MILK) intervention, recruitment, retention, and obtain data for sample size estimation. This study will advance nursing science and practice because it will inform our R01 RCT to examine the efficacy of M-MILK to attenuate adverse effects of early life toxic stress in preterm infants.

Enrollment

14 patients

Sex

All

Ages

Under 1 year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • born between 22 to 34 weeks gestational age and receiving mother's own milk and/or donor milk.

Exclusion criteria

  • receiving only formula, oral cavity defects, gastrointestinal defects, chromosomal abnormalities, severe cardiac defects that require surgery, or intraventricular hemorrhage grade III or IV

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

14 participants in 2 patient groups

Control
No Intervention group
Description:
Infants in the control group will receive standard of care.
M-MILK
Experimental group
Description:
Infants in the M-MILK group will receive the M-MILK intervention in addition to standard of care.
Treatment:
Other: Multisensory Early Oral Administration of Human Milk (M-MILK)

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Thao Griffith, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems